Public invited to free screening of "Addiction Incorporated"
Contact: Kristal Griffith
IASLC Director of Communications
Release: Sept. 30, 2013
Documentary features tobacco industry scientist/whistleblower; panel discussion follows
SYDNEY - The International Association for the Study of Lung Cancer (IASLC) and its Tobacco Control and Prevention Committee invite the public to a free screening of the documentary “Addiction Incorporated” at 10 a.m. Sunday, October 27 in the Bayside Auditorium B at the Sydney Convention & Exhibition Centre. This will be a major focus for the World Conference on Lung Cancer being held Oct. 27-30 at the Convention Centre.
The movie profiles the true story of Victor DeNoble, who was a research scientist at a major tobacco company. DeNoble, who became a whistleblower, was tasked with finding a substitute for nicotine. His research ended up proving cigarettes were addictive.
“We take it for granted now that people know cigarettes are addictive,” says Dr. Carolyn Dresler, member of the IASLC Board of Directors. “Decades ago it wasn’t common knowledge to scientists or the public outside of the tobacco industry. This movie will give people a perspective on what the tobacco industry knew and when.”
The documentary will be followed by a panel discussion led by Dr. Dresler and Mike Daube, professor of Health Policy at Curtin University.
“While the movie will set the stage for where we’ve come, our panel discussion will give attendees a feel for where we are today on tobacco control and prevention issues around the world,” Dresler says. “We have come very far, but we have a long way to go still.”
Professor Mike Daube, president of the Australian Council on Smoking and Health, said, “This is a stunning insight into the way Big Tobacco works. Dr. De Noble’s story shows how desperate the industry was about the massive harms caused by its products – and how cynically they acted when their own research came up with results that incriminated the product.”
The event is part of the program of the IASLC’s 15th World Conference on Lung Cancer. The Conference brings in top researchers in lung cancer and thoracic oncology from around the world. This year’s Conference expects nearly 5,000 delegates from more than 100 countries.
About the 15th WCLC:
The World Conference on Lung Cancer (WCLC) is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. The 2013 theme is “Next-Generation Lung Cancer Care.” More than 4,000 delegates are expected to come from more than 100 countries to discuss the latest developments in thoracic malignancy research. Attendees include surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, basic research scientists, nurses and allied health professionals and patients.
About the IASLC:
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association’s membership includes more than 3,500 lung cancer specialists in 80 countries. To learn more about IASLC please visit www.iaslc.org.